TDC
PTLA

Thompson Davis & Co’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Thompson Davis & Co’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$46K Buy
+1,730
New +$56.5K 0.1% 215
2018
Q2 		– Sell
-125
Closed -$4K – 782
2018
Q1 		$4K Hold
125
– – 0.01% 530
2017
Q4 		$6K Buy
+125
New +$6.32K 0.01% 512

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Thompson Davis & Co's PTLA Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018: 1,730 shares worth $46K. The stake represents 0.1% of the portfolio and ranks #215 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in PTLA as recently as Q1 2018.

Thompson Davis & Co first reported a position in PTLA in Q4 2017 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

  • Thompson Davis & Co held 1,730 shares of Portola Pharmaceuticals, Inc. worth $46K as of Q3 2018.
  • Portola Pharmaceuticals, Inc. was a new Thompson Davis & Co position in Q3 2018.
  • Portola Pharmaceuticals, Inc. made up 0.1% of Thompson Davis & Co's portfolio in Q3 2018, its #215 holding.
  • Thompson Davis & Co first reported a position in Portola Pharmaceuticals, Inc. in Q4 2017 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.